ats-13-04
ats-13-02
ats-13-04
ats-13-02

ATS-13® Activity Assay

What is your testing algorithm for patients suspected of having thrombotic thrombocytopenic purpura (TTP)?

ATS-13 Activity Assay provides protocols to quantitatively measure ADAMTS-13 protease activity and determine the presence of inhibitory antibodies to ADAMTS-13 in human plasma.

ADAMTS-13 is the protease that cleaves von Willebrand Factor. Significant decreases or an absence of ADAMTS-13 activity can lead to the formation of ultra-large vWF fragments and trigger intravascular platelet aggregation and microthrombosis, causing the signs and symptoms of thrombotic thrombocytopenic purpura, TTP.

Quick and Easy

  • Set up in less than 10 minutes
  • Pre-diluted calibrators
  • Results in under 45 minutes

Sensitive

  • Utilises fluorescence resonance energy transfer (FRET) technology with less test variability
  • % Activity and % Inhibition derived from a fluorescent endpoint

Research Use Only (RUO). Not for use in diagnostic procedures.

Resource Library

Our Certifications

Related Products

pipetting-lab-04

Factor VIII Antibody Screen

luminex-lab-07

PF4 Enhanced® and PF4 IgG Assay​

Upcoming Events,
Webinars & Workshops

Upcoming Event

Hot Topic in Transplant Medicine

When

May 25th 2022

Where

Virtual

Upcoming Event

ISHI Webinar Session No 16

When

May 27th 2022

Where

Virtual

Upcoming Event

ISHI Webinar Session No 17

When

June 24th 2022

Where

Virtual

Experience Our Virtual Lab

Seeing Beyond Limits

  • Transfuse
  • Transplant
  • Transform a Life
Immucor

2 Cranbrook Way, Solihull Business Park, Solihull, West Midlands B90 4GT

Call 0330 3338742

Fax 0330 333 8749

Email [email protected]